It may be uniquely beneficial for individuals with related conditions like type 2 diabetes, hypertension, or hypercholesterolemia
Wewer Albrechtsen NJ, Albrechtsen R, Bremholm L, Svendsen B, Kuhre RE, Poulsen SS, Christiansen CB, Jensen EP, Janus C, Hilsted L, Deacon CF, Hartmann B, and Holst JJ
Clinical evidence: The SURMOUNT-1 trial, published in the New England Journal of Medicine , showed that participants on the highest dose of tirzepatide (15 mg) lost an average of 22.5 percent of their body weight over 72 weeks the most weight loss ever demonstrated by a pharmaceutical agent in a clinical trial (Jastreboff et al., 2022)
HSA and FSA cards are accepted for most visits and prescriptions
Talk to your healthcare provider or a nutritionist for personalized advice